ET

Eti Tandon

Active Director Director DIN 08423096
DIN 08423096 First appointment Apr 2019 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Eti Tandon

Data last updated:

Eti Tandon is a Director at Bio Tab Pharmaceuticals Private Limited (since 2019). The company operates in Home Appliances. Bio Tab Pharmaceuticals Private Limited reported revenue of ₹35.5 Lakh (FY 2025).

DIN 08423096
Primary Designation Director
Industry Home Appliances
First Appointment 16 Apr 2019
Oldest Company Age 7 yrs
Largest company Bio Tab Pharmaceuticals Private Limited · ₹35.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20192019₹35.5 Lakh (FY 2025)Active

Board colleagues of Eti Tandon

NameDINCompanyDesignation
Arvind Kumar Tandan08423097Bio Tab Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bio Tab Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Eti Tandon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eti Tandon

Eti Tandon currently holds 1 directorship: Bio Tab Pharmaceuticals Private Limited (Director, since 16 Apr 2019, revenue ₹35.5 Lakh (FY 2025)).

Eti Tandon was first appointed on 16 Apr 2019 as Director at Bio Tab Pharmaceuticals Private Limited.

The current boards of Eti Tandon's companies include Arvind Kumar Tandan (Bio Tab Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available